The 20 linked references in paper S. Banov M., A. Golanov V., S. Ilyalov R., E. Vetlova R., S. Maryashev A., D. Naskhletashvili R., I. Osinov K., V. Kostuchenko V., A. Durgaryan A., С. Банов М., А. Голанов В., С. Ильялов Р., Е. Ветлова Р., С. Маряшев А., Д. Насхлеташвили Р., И. Осинов К., В. Костюченко В., А. Дургарян А. (2017) “РЕЗУЛЬТАТЫ РАДИОХИРУРГИЧЕСКОГО И ЛЕКАРСТВЕННОГО ЛЕЧЕНИЯ ПАЦИЕНТОВ С МЕТАСТАЗАМИ В ГОЛОВНОЙ МОЗГ // RESULTS OF RADIOSURGICAL AND DRUG TREATMENT OF PATIENTS WITH BRAIN METASTASES” / spz:neicon:ogsh:y:2017:i:3:p:19-30

  1. 04;22(14):2865–72. DOI: 10.1200/JCO. 2004.12.149. PMID: 15254054. 2. Lippitz B., Lindquist C., Paddick I. et al. Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Canc Treat Rev 2014;40(1):48–59. DOI: 10.1016/j.ctrv.2013.05.002. PMID: 23810288.
  2. Lo S. S., Clarke J. W., Grecula J. C. et al. Stereotactic radiosurgery alone for patients with 1–4 radioresistant brain metastases. Med Oncol 2011;28(1):439–44. DOI: 10.1007/s12032-010-9670-5.
  3. Vogelbaum M. A., Suh J. H. Resectable brain metastases. J Clin Oncol 2006;8(24):1289–1294. DOI: 10.1200/JCO.2005.04.6235. PMID: 16525184.
  4. Yamamoto M., Serizawa T., Shuto T. et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 2014; 15(4):387–95. DOI: 10.1016/S1470–2045(14)70061–0. PMID: 24621620.
  5. Andrews D. W., Scott C. B., Sperduto P. W. et al. Whole Brain Radiation Therapy with or Without Stereotactic Radiosurgery Boost for Patients with One to Three Brain Metastases: Phase III Results of the RTOG 9508 Randomised Trial. Lancet (London, England) 2004;363(9422):1665–72. DOI: 10.1016/S0140–6736 (04)16250–8.
  6. Muacevic A., Wowra B., Siefert A. et al. Microsurgery Plus Whole Brain Irradiation Versus Gamma Knife Surgery Alone for Treatment of Single Metastases to the Brain: a Randomized Controlled Multicentre Phase III Trial. J Neurooncol 2008;87(3):299–307. DOI: 10.1007/s11060-007-9510-4.
  7. Serizawa T., Yamamoto M., Sato Y et al. Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study. J Neurosurg 2010;113:48–52. DOI: 10.3171/2010.8. GKS10838. PMID: 21121787.
  8. Tendulkar R. D., Liu S. W., Barnett G. H. et al. RPA classification has prognostic significance for surgically resected single brain metastasis. Int J Radiat Oncol Biol Phys 2006;66(3):810–7. DOI: 10.1016/j.ijrobp.2006.06.003. PMID: 17011454.
  9. Patchell R. A., Regine W. F. The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases. Technol Cancer Res Treat 2003;2(2):111–5. DOI: 10.1177/153303460300200206. PMID: 12680791.
  10. Yu C. P., Cheung J. Y., Chan J. F. et al. Prolonged survival in a subgroup of patients with brain metastases treated by gamma knife surgery. J Neurosurg 2005;102(Suppl.):262–5. DOI: 10.3171/jns.2005.102.s_supplement.0262. PMID: 28306476.
  11. Golden D. W., Lamborn K. R., McDermott M.W. et al. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg 2008;109:77–86. DOI: 10.3171/JNS/2008/109/12/S13.
  12. Karlsson B., Hanssens P., Wolff R. et al. Thirty years» experience with Gamma Knife surgery for metastases to the brain. J Neurosurg 2009;111(3): 449–57. DOI: 10.3171/2008.10.JNS08214. PMID: 19199505.
  13. Sperduto P. W., Berkey B., Gaspar L. E. et al. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;2(70):510–4. DOI: 10.1016/j.ijrobp.2007.06.074. PMID: 17931798. Конфликт интересов. Авторы заявляют об отсутствии конфликта интересов. Conflict of interest. Authors declare no conflict of interest. таргетной терапии и радиохирургии, однако требуется проведение проспективных исследований для оценки ее эффективности и нейротоксичности. Заключение Результаты проведенного авторами анализа показали эффективность радиохирургического лечения в целом в группе пациентов с метастазами в головной мозг. Общая выживаемость пациентов в общей группе больных
  14. Aoyama H., Shirato H., Tago M. et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006:21(295):2483–91. DOI: 10.1001/jama. 295.21.2483. PMID: 16757720.
  15. Kocher M., Soffietti R., Abacioglu U. et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952– 26001 study. J Clin Oncol 2011;2(29):134–41. DOI: 10.1200/JCO. 2010.30.1655. PMID: 21041710.
  16. Kwon K. Y., Kong D. S., Lee J. I. et al. Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg 2007;109(2):132–41. DOI: 10.1016/j.clineuro.2006.06.007. PMID: 16930821.
  17. Shen C. J., Rigamonti D., Redmond K. J. et al. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases. Pract Radiat Onco 2016;6(6):409–16. DOI: 10.1016/j.prro.2016.04.004. PMID: 27687187.
  18. Yomo S., Hayashi M., Cho N. Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer. J Neurooncol 2013;112(2):199–207. DOI: 10.1007/s11060-013-1046-1. PMID: 23296546.
  19. Johung K. L., Yao X., Li F. et al. A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clin Cancer Res 2013;19(19):5523–32. DOI: 10.1158/1078–0432.CCR-13–0836. PMID: 23897899.
  20. Patel K. R., Chowdhary M., Switchenko J. M. et al. BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis. Melanoma Res 2016;26(4):387–94. DOI: 10.1097/CMR. 0000000000000268. PMID: 27223498.